Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 122295
Published online Aug 19, 2026. doi: 10.5498/wjp.122295
Published online Aug 19, 2026. doi: 10.5498/wjp.122295
Table 1 Baseline characteristics of study subjects, n (%)/mean ± SD
| Characteristics | Total (n = 125) | Non-anxiety-depression group (n = 69) | AD group (n = 56) | P value |
| Age (years) | 72.8 ± 8.6 | 71.9 ± 8.2 | 73.9 ± 9.0 | 0.198 |
| Male gender | 56 (44.8) | 32 (46.4) | 24 (42.9) | 0.696 |
| MMSE score | 18.4 ± 4.2 | 19.4 ± 4.2 | 17.2 ± 4.0 | 0.004 |
| IL-6 (pg/mL) | 12.4 ± 4.8 | 9.6 ± 3.1 | 15.8 ± 4.2 | < 0.001 |
| TNF-α (pg/mL) | 22.8 ± 7.6 | 18.2 ± 5.4 | 28.4 ± 6.8 | < 0.001 |
| p-tau181 (pg/mL) | 20.1 ± 6.2 | 16.4 ± 4.2 | 24.6 ± 5.8 | < 0.001 |
- Citation: Hu X, Tao J, Jiang YL, Liu K. Predictive value of serum inflammatory factors combined with p-tau181 for anxiety and depression in Alzheimer’s disease patients. World J Psychiatry 2026; 16(8): 122295
- URL: https://www.wjgnet.com/2220-3206/full/v16/i8/122295.htm
- DOI: https://dx.doi.org/10.5498/wjp.122295